Antimicrobial agent resistance.
- Published in:
- 2002
- By:
- Publication type:
- Journal Article
Works matching IS 1082801X AND DT 2002 AND VI 37 AND IP 6
Results: 68
1
2
Pharmacodynamics of the quinolones.
- Published in:
- 2002
- By:
- Publication type:
- Journal Article
3
Overview of the fluoroquinolones: focus on moxifloxacin.
- Published in:
- 2002
- By:
- Publication type:
- Journal Article
4
Moxifloxacin: a once-daily, fourth-generation fluoroquinolone antibiotic.
- Published in:
- 2002
- Publication type:
- Journal Article
5
General safety of moxifloxacin.
- Published in:
- 2002
- By:
- Publication type:
- Journal Article
6
The potency/efficacy of the fluoroquinolones in community-acquired pneumonia.
- Published in:
- 2002
- By:
- Publication type:
- Journal Article
7
Ciprofloxacin: a highly active fluoroquinolone with a wide range of gram-negative and gram-positive activity.
- Published in:
- 2002
- Publication type:
- Journal Article
8
GENERAL SAFETY OF MOXIFLOXACIN.
- Published in:
- Formulary, 2002, v. 37, n. 6, p. 32
- By:
- Publication type:
- Article
9
THE POTENCY/EFFICACY OF THE FLUOROQUINOLONES IN COMMUNITY-ACQUIRED PNEUMONIA.
- Published in:
- Formulary, 2002, v. 37, n. 6, p. 27
- By:
- Publication type:
- Article
10
ANTIMICROBIAL AGENT RESISTANCE.
- Published in:
- Formulary, 2002, v. 37, n. 6, p. 20
- By:
- Publication type:
- Article
11
OVERVIEW OF THE FLUOROQUINOLONES focus on moxifloxacin.
- Published in:
- Formulary, 2002, v. 37, n. 6, p. 13
- By:
- Publication type:
- Article
12
MOXIFLOXACIN: a once-daily, fourth-generation fluoroquinolone antibiotic Product Profile.
- Published in:
- Formulary, 2002, v. 37, n. 6, p. 9
- Publication type:
- Article
13
CIPROFLOXACIN: a highly active fluoroquinolone with a wide range of gram-negative and gram-positive activity Product Profile.
- Published in:
- Formulary, 2002, v. 37, n. 6, p. 4
- Publication type:
- Article
14
Few CHF patients achieve target dosages of beta blockers, risking hospitalizations and death.
- Published in:
- 2002
- Publication type:
- Journal Article
15
Changes in HMO drug management strategies, 2000 vs 1999.
- Published in:
- 2002
- Publication type:
- Journal Article
16
Drug and formulary factoids.
- Published in:
- 2002
- Publication type:
- Journal Article
17
Reasons why people are reluctant to participate in clinical trials.
- Published in:
- 2002
- Publication type:
- Journal Article
18
Long-term trials show good response to new anti-RA biologic.
- Published in:
- 2002
- Publication type:
- Journal Article
19
Years on market before expiration of first patent.
- Published in:
- 2002
- Publication type:
- Journal Article
20
Beyond depression: evaluation of newer indications and off-label uses for SSRIs.
- Published in:
- 2002
- By:
- Publication type:
- Journal Article
21
Rheumatoid arthritis: update on the newest DMARDs and their potential place in therapy.
- Published in:
- 2002
- By:
- Publication type:
- Journal Article
22
Focus on ... Tadalafil: an oral selective phosphodiesterase 5 inhibitor for treatment of erectile dysfunction.
- Published in:
- 2002
- By:
- Publication type:
- Journal Article
23
Antibiotics won't do anything for acute bronchitis.
- Published in:
- 2002
- Publication type:
- Journal Article
24
Spending on direct-to-consumer advertising and promotion to health care professionals, 1996 through 2000.
- Published in:
- 2002
- Publication type:
- Journal Article
25
Inhaled insulin regimen looks equal to or better than shots alone for type 1 diabetes.
- Published in:
- 2002
- Publication type:
- Journal Article
26
Black-box warnings added against immunosuppressant's use in liver transplants.
- Published in:
- 2002
- Publication type:
- Journal Article
27
Serious events associated with abortifacient prompt letter but no labeling change.
- Published in:
- 2002
- Publication type:
- Journal Article
28
Adverse events added to terazosin HCI (Hytrin) labeling.
- Published in:
- 2002
- Publication type:
- Journal Article
29
Drug shortage update.
- Published in:
- 2002
- Publication type:
- Journal Article
30
Statins may increase polyneuropathy risk.
- Published in:
- 2002
- Publication type:
- Journal Article
31
Warning letters issued on intravenous immune globulin administration.
- Published in:
- 2002
- Publication type:
- Journal Article
32
Fluid retention warnings strengthened on two diabetes drugs.
- Published in:
- 2002
- Publication type:
- Journal Article
33
Strict fetal protection program instituted and bone health warnings added for isotretinoin.
- Published in:
- 2002
- Publication type:
- Journal Article
34
New indications. Vioxx.
- Published in:
- 2002
- Publication type:
- Journal Article
35
Serious adverse drug reactions called more frequent with recently approved drugs.
- Published in:
- 2002
- Publication type:
- Journal Article
36
New molecular entities. SecreFlo.
- Published in:
- 2002
- Publication type:
- Journal Article
37
First-time generics.
- Published in:
- 2002
- Publication type:
- Journal Article
38
Upcoming advisory meetings.
- Published in:
- 2002
- Publication type:
- Journal Article
39
Orphan drug designations.
- Published in:
- 2002
- Publication type:
- Journal Article
40
Fast-track designations.
- Published in:
- 2002
- Publication type:
- Journal Article
41
Recommendation for a return to market.
- Published in:
- 2002
- Publication type:
- Journal Article
42
Priority review designation.
- Published in:
- 2002
- Publication type:
- Journal Article
43
Approvable designations.
- Published in:
- 2002
- Publication type:
- Journal Article
44
Recommendations for approval.
- Published in:
- 2002
- Publication type:
- Journal Article
45
Antibacterial and antifungal agents.
- Published in:
- Formulary, 2002, v. 37, n. 6, p. 322
- Publication type:
- Article
46
Selected web sites.
- Published in:
- Formulary, 2002, v. 37, n. 6, p. 322
- Publication type:
- Article
47
Selected literature.
- Published in:
- Formulary, 2002, v. 37, n. 6, p. 322
- Publication type:
- Article
48
Few CHF patients achieve target dosages of beta blockers, risking hospitalizations and death.
- Published in:
- Formulary, 2002, v. 37, n. 6, p. 321
- By:
- Publication type:
- Article
49
Drug and Formulary Trends.
- Published in:
- Formulary, 2002, v. 37, n. 6, p. 320
- Publication type:
- Article
50
Beyond depression: Evaluation of newer indications and off-label uses for SSRIs.
- Published in:
- Formulary, 2002, v. 37, n. 6, p. 312
- By:
- Publication type:
- Article